Drug Profile
Testosterone-transdermal TheraDerm LRS - AbbVie
Alternative Names: Androderm; Androflex; Andropatch; AtmosLatest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator Watson Laboratories
- Developer Endo International
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action DNA-directed RNA polymerase stimulants; Protein synthesis stimulants; Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypogonadism